OC Business Journal

Stem cell, fat processing platform Sayenza Biosciences raising $4M

an Orange-based medical equipment manufacturer, is looking to raise a $4 million seed round for its automated fat and stem cell processor.

Sayenza aims to streamline fat processing for cosmetic and regenerative medicine applications with a device that separates stem cells from fat in 15 minutes. Current fat processing methods take about two hours to complete and require careful attention from surgeons, which risk contamination, according to Sayenza founder and CEO Derek Banyard.

The resulting adipose-derived stem cell injectables from Sayenza’s technology will potentially be applicable to heart tissue, bone and nerve restoration, along with cosmetic enhancements.

By entering the cosmetics and regenerative medicine market, Sayenza has the potential to generate roughly $620 million in annual revenue by 2028, Banyard said.

The company, founded this year at the University of California, Irvine’s Wayfinder program, has raised about $125,000 to date. Banyard currently serves as the founder and executive director of the Arthur L. Garnes Society, a mentorship program for underrepresented minorities in plastic surgery, as well as the regenerative medicine subcommittee member of the American Society of Plastic Surgeons. He previously co-founded Irvine medical device company Syntr Health Technologies Inc. and was a resident scholar at UCI Health.

TABLE OF CONTENTS

en-us

2022-12-05T08:00:00.0000000Z

2022-12-05T08:00:00.0000000Z

https://ocbusinessjournal.pressreader.com/article/281621014360331

LABJ